论文部分内容阅读
1文献来源 Thomas DA, O＇Brien S, Faderl S, et al. Chemoimmunotherapy with a modified Hyper-CVAD and Rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia [J]. J Clin Oncol, 2010,28（24） ：